Compensatory Kinematic Movements in Various Directions After Stroke

Sponsor
University of Valencia (Other)
Overall Status
Recruiting
CT.gov ID
NCT05683158
Collaborator
Ulsan National Institute of Science and Technology (Other)
100
1
11
9.1

Study Details

Study Description

Brief Summary

This is cross-sectional study. By comparing kinematic analysis between stroke and healthy subjects in various directions, this investigation analyzes the compensatory kinematic movement for reaching task in stroke survivors

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    After Institutional Review Board approval, It recruits 2 groups. one group is elderly and another group is stroke survivors. the stroke group that meets the criteria. Another group is age matching of the stroke and not having an orthopedic or neurological disease. Participants of all the groups are assessed for kinematic by motion capture During reaching arm(affected side; stroke group, non-dominant side; healthy group) in 3 directions(medial_45, forward_90 and lateral_120 degrees). Retroreflective markers are placed on 11 anatomical place (3th metacarpal joint, both acromion, elbow lateral and medial epicondyle, lateral and medial styloid process, xyphoid process, sternum, C7, T4). Participants reach to a bell as quickly as possible in three directions. The subject reach to a bell 5 times in each direction and assess clinical evaluation such as Fugl Meyer Assessment, Postural Assessment Scale, Modified Ashworth Scale, shoulder-elbow range of motion and Trunk Instability scale.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Compensatory Kinematic Movement for Reaching Task in Various Directions in After Stroke
    Actual Study Start Date :
    Aug 10, 2022
    Anticipated Primary Completion Date :
    May 10, 2023
    Anticipated Study Completion Date :
    Jul 10, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    chronic stroke

    The subject consisted of the physician's confirmation of chronic hemiplegia onset ≥ 6 months Mini-mental state examination≥25 Biceps ≤2, Triceps≤2 Ability to Sit on a chair alone FMA upper extremity score ≥ 21points, FMA upper extremity score ≤ 66 points The symptom is mild or moderate level (MAS≤2) and can sit alone. The subject reaches to target by affected arm in 3 directions(medial_45, forward_90 and lateral_120 degrees)

    Healthy

    Matching aged people, not having neurological system or orthopedic disease on Upper extremity. The subject reaches to target by non-dominant arm in 3 directions(medial_45, forward_90 and lateral_120 degrees)

    Outcome Measures

    Primary Outcome Measures

    1. Difference of the components temporal measurements between healthy and stroke [1 time(Baseline)]

      Hand velocity(peak velocity of 3th metacarpal phalangeal joint marker in reaching phase in millimetres per second; mm/s),total movement time in second, reaching time in second, number of movement units. elbow angular acceleration(elbow angular velocity per unit time; rad/sec2) and elbow angular velocity(time rate at which an object rotates, or revolves, about an axis, or at which the angular displacement between two forearm and humerus; rad/s) in reaching 3 directions(medial_45, forward_90 and lateral_120 degrees). Participants reach to a bell as quickly as possible. 3th joint is calculated for quantitative measurements.

    2. Difference of the components spatial measurements between healthy and stroke [1 time(Baseline)]

      Trunk dislocation of reaching phase in millimetre; mm), elbow and shoulder angle in reaching in degree. The measurements are detected by 3 directions(medial_45, forward_90 and lateral_120 degrees). Participants reach to a bell as quickly as possible. 3th joint is calculated for quantitative measurements.

    Secondary Outcome Measures

    1. Relationship between clinical score and kinematic variable in each direction [1 time(Baseline)]

      Related FMA score(dependent) to predictors(independent) in three directions.

    Other Outcome Measures

    1. Modified Ashworth Scale_Stiffness of chronic stroke [1 time(Baseline)]

      Scoring for Biceps and Triceps MAS 0: No increase in tone MAS 1: slight increase in tone giving a catch when slight increase in muscle t-tone, manifested by the limb was moved in flexion or extension. MAS 1+: slight increase in muscle tone, manifested by a catch followed by minimal resistance throughout (ROM ) MAS 2: more marked increase in tone but more marked increased in muscle tone through most limb easily flexed MAS 3: considerable increase in tone, passive movement difficult MAS 4: limb rigid in flexion or extension

    2. Range of motion_Health status chronic stroke [1 time(Baseline)]

      Shoulder and elbow joint range of motion Shoulder flexion, adduction, abduction, external rotation, internal rotation Elbow flexion, extension

    3. Trunk impairment scale(TIS)_Health status chronic stroke [1 time(Baseline)]

      Static sitting balance Dynamic sitting balance Coordination Total score is 23 points

    4. Postural assessment scale for stroke(PASS)_Health status chronic stroke [1 time(Baseline)]

      Maintaining posture Sitting without support Standing with support Standing without support Standing on non paretic leg Standing on paretic leg Changing a posture 6.Supine to paretic side lateral 7.Supine to non-paretic side lateral 8.Supine to sitting up on the edge mat 9.Sitting on the edge of mat to supine 10.Sitting to standing up 11.Standing up to sitting down 12.Standing, picking up a pencil from the floor Total score is 36 points

    5. Fugl_Meyer Assessment(FMA)_Health status chronic stroke [1 time(Baseline)]

      Upper extremity Shoulder, Elbow and Forearm Reflex activity Volitional movement within synergies Volitional movement mixing synergies Volitional movement with little or no synergy Normal reflex activity Wrist Hand Coordination/Speed Total score is 66 points

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    The inclusion criteria used in the randomized controlled trials were as follows:

    Stroke

    • Subject consisted of the physician's confirmation of chronic hemiplegia

    • onset ≥ 6 months

    • Mini-mental state examination≥25

    • Biceps ≤2, Triceps≤2

    • Ability to Sit on a chair alone

    • FMA upper extremity score ≥ 21 points, FMA upper extremity ≤ 66 points

    Healthy

    • Age of matching the stroke group

    • Absence of neurological disease and orthopedic disease

    Exclusion Criteria:

    Stroke

    • Biceps>2, Triceps>2

    • Flaccid

    • Neglect syndrome

    • Have neurological disease and orthopedic disease

    • Lack of coordination

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ulsan National Institute of Science and Technology Ulsan Ulju Korea, Republic of 44919

    Sponsors and Collaborators

    • University of Valencia
    • Ulsan National Institute of Science and Technology

    Investigators

    • Principal Investigator: Jóse Casaña Granell, PhD, University of Valencia
    • Principal Investigator: Joaquin Calatayud Villalba, PhD, University of Valencia
    • Principal Investigator: Sang Hoon Kang, PhD, Ulsan National Institute of Science and Technology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    José Casaña Granell, Principal Investigator, University of Valencia
    ClinicalTrials.gov Identifier:
    NCT05683158
    Other Study ID Numbers:
    • Kinematic movements of stroke
    First Posted:
    Jan 12, 2023
    Last Update Posted:
    Jan 19, 2023
    Last Verified:
    Jan 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by José Casaña Granell, Principal Investigator, University of Valencia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 19, 2023